Publicacións nas que colabora con María Pérez Mato (19)

2024

  1. New Perspectives in Neuroprotection for Ischemic Stroke

    Neuroscience

  2. Pharmacological preclinical comparison of tenecteplase and alteplase for the treatment of acute stroke

    Journal of Cerebral Blood Flow and Metabolism, Vol. 44, Núm. 8, pp. 1306-1318

  3. Precision Medicine for Blood Glutamate Grabbing in Ischemic Stroke

    International Journal of Molecular Sciences, Vol. 25, Núm. 12

2022

  1. Surrogate biomarkers of outcome for wake-up ischemic stroke

    BMC Neurology, Vol. 22, Núm. 1

2021

  1. Characterization of a temporal profile of biomarkers as an index for ischemic stroke onset definition

    Journal of Clinical Medicine, Vol. 10, Núm. 14

  2. sTWEAK as Predictor of Stroke Recurrence in Ischemic Stroke Patients Treated With Reperfusion Therapies

    Frontiers in Neurology, Vol. 12

2020

  1. NT-pro-BNP: A novel predictor of stroke risk after transient ischemic attack

    International Journal of Cardiology, Vol. 298, pp. 93-97

  2. Regulatory T cells participate in the recovery of ischemic stroke patients

    BMC Neurology, Vol. 20, Núm. 1

  3. Temperature-induced changes in reperfused stroke: Inflammatory and thrombolytic biomarkers

    Journal of Clinical Medicine, Vol. 9, Núm. 7, pp. 1-12

  4. The presence of leukoaraiosis enhances the association between sTWEAK and hemorrhagic transformation

    Annals of Clinical and Translational Neurology, Vol. 7, Núm. 11, pp. 2103-2114

2018

  1. Clinical validation of blood/brain glutamate grabbing in acute ischemic stroke

    Annals of Neurology, Vol. 84, Núm. 2, pp. 260-273

2017

  1. Endothelial progenitor cells as a therapeutic approach for intracerebral hemorrhage

    Current Pharmaceutical Design, Vol. 23, Núm. 15, pp. 2238-2251

2016

  1. Increased Endothelial Progenitor Cell Levels are Associated with Good Outcome in Intracerebral Hemorrhage

    Scientific Reports, Vol. 6

2013

  1. Hyperthermia in human ischemic and hemorrhagic stroke: Similar outcome, different mechanisms

    PLoS ONE, Vol. 8, Núm. 11

2012

  1. Increased levels of circulating endothelial progenitor cells in patients with ischaemic stroke treated with statins during acute phase

    European Journal of Neurology, Vol. 19, Núm. 12, pp. 1539-1546

  2. Temporal profile of molecular signatures associated with circulating endothelial progenitor cells in human ischemic stroke

    Journal of Neuroscience Research, Vol. 90, Núm. 9, pp. 1788-1793

2011

  1. Blood levels of glutamate oxaloacetate transaminase are more strongly associated with good outcome in acute ischaemic stroke than glutamate pyruvate transaminase levels

    Clinical Science, Vol. 121, Núm. 1, pp. 11-17

  2. CDP-choline treatment increases circulating endothelial progenitor cells in acute ischemic stroke

    Neurological Research, Vol. 33, Núm. 6, pp. 572-577

  3. Cd34 +progenitor cells likely are involved in the good functional recovery after intracerebral hemorrhage in humans

    Journal of Neuroscience Research, Vol. 89, Núm. 7, pp. 979-985